Citation Impact
Citing Papers
Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol
2012
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial
2014
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
2016
Protein modification and maintenance systems as biomarkers of ageing
2015
Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis
2009
Cytokines in inflammatory bowel disease
2014 Standout
Factors Associated With Poor Outcomes in Adults With Newly Diagnosed Ulcerative Colitis
2014
Role of endoscopy in predicting the disease course in inflammatory bowel disease
2010
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis
2009
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
2015
Conventional Medical Management of Inflammatory Bowel Disease
2011
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004
2004
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
2013 Standout
Mucosal healing as an index of colitis activity: Back to histological healing for future indices
2010
Graphical presentation of diagnostic information
2008
Rheumatoid arthritis
2016 Standout
Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance
2010
Intestinal homeostasis and its breakdown in inflammatory bowel disease
2011 StandoutNature
Ulcerative Colitis
2011 Standout
Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis
2010
Inefficacy of infliximab in primary Sjögren's syndrome: Results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSS)
2004
HLA shared epitope and ACPA: Just a marker or an active player?
2013
Type I interferon blockade in systemic lupus erythematosus: where do we stand?
2013
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
2005
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease
2015
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates
2010
Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases
2014 Standout
Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
2010
Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNFα
2004
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Guidelines for the management of inflammatory bowel disease in adults
2011
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Updated consensus statement on biological agents, specifically tumour necrosis factor α (TNFα) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005
2005
Alterations of the synovial T cell repertoire in anti–citrullinated protein antibody–positive rheumatoid arthritis
2009
Crohn's disease
2012 Standout
Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
2012
The Oslo definitions for coeliac disease and related terms
2012 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Infliximab treatment for refractory Kawasaki syndrome
2005
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents
2012
Anti-TNF-alpha therapy in ankylosing spondylitis
2006
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease
2010
Endoscopic monitoring of infliximab therapy in Crohnʼs disease
2010
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
2011
Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding
2012
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease
2017
Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis
2010
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
2011
Celiac Disease
2007 Standout
Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis
2011
Predicting Endoscopic Crohnʼs Disease Activity Before and After Induction Therapy in Children
2015
Future biologic targets for IBD: potentials and pitfalls
2010
Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy
2013
Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab
2011
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)
2009
Mucosal Healing in Inflammatory Bowel Disease: Where Do We Stand?
2010
Ulcerative colitis
2012 Standout
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
2011 Standout
Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitis
2009
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Chronic inflammatory diseases: Do immunological patterns drive the choice of biotechnology drugs? A critical review
2014
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
Systemic Lupus Erythematosus
2011 Standout
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
2016
Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis
2016
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
2011
Ulcerative colitis
2016 Standout
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
2013
Cellular and Molecular Mechanisms of Pain
2009 StandoutNobel
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Optimizing anti-TNF treatments in inflammatory bowel disease
2013
Mucosal Healing: Impact on the Natural Course or Therapeutic Strategies
2009
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis
2009
Regulation of type I interferon responses
2013 Standout
Clinical implications of mucosal healing for the management of IBD
2009
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
2013 Standout
Accuracy of Magnetic Resonance Enterography in Assessing Response to Therapy and Mucosal Healing in Patients With Crohn's Disease
2013
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases
2019 Standout
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
2014
Utility in Clinical Practice of Immunoglobulin A Anti-Tissue Transglutaminase Antibody for the Diagnosis of Celiac Disease
2006
Mucosal Healing in Crohnʼs Disease
2012
Comparison of Outcomes Parameters for Induction of Remission in New Onset Pediatric Crohnʼs Disease
2014
Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis
2013
Macrophage Cytokines: Involvement in Immunity and Infectious Diseases
2014 Standout
New targets for mucosal healing and therapy in inflammatory bowel diseases
2013
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
2015
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
2016 Standout
Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease
2012
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Colectomy rate in acute severe ulcerative colitis in the infliximab era
2008
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
2012
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
2011 Standout
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
2015
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
The use of fecal calprotectin and lactoferrin in patients with IBD. Review.
2013
Antibodies against Synthetic Deamidated Gliadin Peptides for Celiac Disease Diagnosis and Follow-Up in Children
2008
Autoimmunity and Anti-TNF-α Agents
2005
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
SIDS and Other Sleep-Related Infant Deaths: Expansion of Recommendations for a Safe Infant Sleeping Environment
2011 Standout
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications
2010
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Das epidemische h�morrhagische Fieber
1956 StandoutNobel
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
The effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications
2005
Pediatric Gastroesophageal Reflux Clinical Practice Guidelines
2018
Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
2010
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
2008
JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
2015
Predictors of Long‐term Clinical and Endoscopic Remission in Children With Crohn Disease Treated With Infliximab
2019
N-glycomic biomarkers of biological aging and longevity: A link with inflammaging
2012
The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity
2011
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
Slight Increases in the Disease Activity Index and Platelet Count Imply the Presence of Active Intestinal Lesions in C-reactive Protein-negative Crohn's Disease Patients
2014
The Emerging Link Between Autoimmune Disorders and Neuropsychiatric Disease
2011
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study
2016
Virus hemorrhagic fevers
1962 StandoutNobel
Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis
2010
Review article: the role of anti‐TNF in the management of ulcerative colitis – past, present and future
2013
Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab.
2005
Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
2011
Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome.
2014
Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti‐TNF therapy
2015
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment
2006
Works of Ilse Hoffman being referenced
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy
2011
A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
2014
Predictors of early response to infliximab in patients with ulcerative colitis
2006
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus
2008
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
2009
Levels of C-reactive Protein Are Associated With Response to Infliximab Therapy in Patients With Crohn's Disease
2011
Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta‐analysis
2005
Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: A prospective study in 154 consecutive patients
2004
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
2008
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy
2003
Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor
2005
Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis
2008
Long-term outcome after infliximab for refractory ulcerative colitis
2008
Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis
2009
Laparoscopic Nissen fundoplication in infants and children: analysis of 106 consecutive patients with special emphasis in neurologically impaired vs. neurologically normal patients
2007
Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry
2005
Duodenogastro-Esophageal Reflux in Children with Refractory Gastro-Esophageal Reflux Disease
2007
Congenital veno‐venous malformations of the liver: Widely variable clinical presentations
2007
Diagnostic Accuracy of Ten Second-Generation (Human) Tissue Transglutaminase Antibody Assays in Celiac Disease
2004
The possible role of histamine in epidemic hemorrhagic fever: an evaluation of antihistamine therapy.
1954
Diagnostic Performance and Predictive Value of Rheumatoid Factor, Anti-citrullinated Peptide Antibodies, and the HLA Shared Epitope for Diagnosis of Rheumatoid Arthritis
2004